Near-infrared fluorescence mammography works with rays of near-infrared (NIR) light instead of X-rays. Although this is thought to be a very promising technique, there have been no effective contrast agents.
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
The Virtual Institute for Seven Tesla Applications (VISTA) is a partnership of several Dutch universities. To evaluate the benefit of ultrahigh-field MRI the first human 7.0T whole-body research scanner, supplied by Philips Medical Systems, was installed at the Leiden University Medical Center (LUMC). Roland Plasterk, the Durch minister of education, culture and science, attended at the opening…
Besides sophisticated imaging technologies, biomarkers are the key to molecular medicine. Therefore, the development of new and more specific biomarkers is the primary aim of researchers around the world and - since this June - it is also the aim of the new founded European Institute of Molecular Imaging, a cooperation project of the University Münster, Germany and Siemens Medical Solutions.…
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.
Whilst Siemens AG in Germany is going through turbulent times, the medical branch of the business remains on steady ground.
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'
In recent years new imaging procedures have delivered many answers and solutions for oncological diagnostics and therapy. However, one question could not be answered: Is a tumour developing?
Eastman Kodak Company has completed the sale of its Health Group to an affiliate of Onex Corporation for up to $2.55 billion. The acquired business is continuing under the name Carestream Health, Inc.
When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the previous discussions about a successor of Klaus Kleinfeld, but hardly anybody knew Loescher´s name in any enconomic context.
Austria - In recent years scientists have produced multi-channel MRI systems, new coil concepts and new contrast media, all of which have helped to shift radiology towards the centre of patient care.
A convenient technology to quantify three-dimensional (3D) morphological features would have widespread applications in biomedical research. Now, researchers from Umea University in Sweden presented a new method for 3D imaging and quantification of biological preparations ten times larger than the limit for traditional confocal microscopes.
GE was the first to undertake molecular imaging development on a large scale. 'You have to be a very special company to work in this discipline,' Reinaldo Garcia, President and Chief Executive Officer of GE Healthcare International, pointed out, when we asked for an update on his company's progress in this field
The European Congress of Radiology (ECR) is a never-ending story of surprises, excitement, and success. Year after year, more scientists, radiologists eager to learn, and partners from industrial companies flock to this excellent meeting.
Aiming for European biomedical research at the highest level.
As information and communications technology (ICT) makes it way into the everyday practice of medicine, the Radiological Society of North America (RSNA) is integrating ICT with clinical presentations at the world's largest healthcare meeting this year.
The First European Institute of Molecular Imaging (EIMI) was foundet at the Westphalian Wilhelms-University in Muenster, Germany.
In an interview with Daniela Zimmermann, Executive Director of European Hospital, Dr Mohammad Naraghi, Head of the Department of Business Development at Siemens Medical Solutions, discussed developments in moleculary medicine, biochips, preventive diagnostics and a comprehensive and integrated health system for the future.
By Stefan G Ruehm MD PhD, Associate Professor of Radiology, at the David Geffen School of Medicine, UCLA, California
Dr Hanns-Joachim Weinmann, Diagnostics and Radiopharmaceuticals, Magnetic Resonance Imaging & X-Ray Research, Schering AG, examines what is feasible and what still lies only at a tantalising distance.
12 distinguished researchers and industry representatives presented the latest molecular medicine research at the Molecular Medicine - from Diagnostics to Therapy symposium - one in a series of annual diagnostics seminars organised by the Forum Medicine Technology & Pharmaceutics e.V.
Generating targeting agents for diagnostics, prognostics and radiotherapy, by designing biochemically specific elements in contrast agents to be the targeting molecules attached to and carrying diagnostic or radiotherapeutic molecules to abnormal cells.
By Dr Fabian Kiessling, Head of the Division of Molecular Imaging, Department of Biophysics and Medical Radiation Physics, German Cancer Research Centre (DKFZ)
